A randomised trial of ondansetron for the treatment of irritable bowel syndrome with diarrhoea

Randomised clinical trial: alosetron improves quality of life and reduces restriction of daily activities in women with severe diarrhoea-predominant IBS

(2012) F. Cremonini et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

The Tryptophan Hydroxylase Inhibitor LX1031 Shows Clinical Benefit in Patients With Nonconstipating Irritable Bowel Syndrome

(2011) Philip M. Brown et al.   GASTROENTEROLOGY

Impaired Uptake of Serotonin by Platelets From Patients With Irritable Bowel Syndrome Correlates With Duodenal Immune Activation

(2011) Stephen Foley et al.   GASTROENTEROLOGY

Ischemic Colitis and Complications of Constipation Associated With the Use of Alosetron Under a Risk Management Plan: Clinical Characteristics, Outcomes and Incidences

(2010) Lin Chang et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Serotonin Signaling Is Altered in Irritable Bowel Syndrome With Diarrhea but Not in Functional Dyspepsia in Pediatric Age Patients

(2010) Christophe Faure et al.   GASTROENTEROLOGY

Postinfectious Irritable Bowel Syndrome

(2009) Robin Spiller et al.   GASTROENTEROLOGY

Postprandial Changes in Small Bowel Water Content in Healthy Subjects and Patients With Irritable Bowel Syndrome

(2009) Luca Marciani et al.   GASTROENTEROLOGY

Predictors of Patient-Assessed Illness Severity in Irritable Bowel Syndrome

(2008) Brennan Spiegel et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Effects of 5-Hydroxytryptamine (Serotonin) Type 3 Antagonists on Symptom Relief and Constipation in Nonconstipated Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

(2008) Viola Andresen et al.   Clinical Gastroenterology and Hepatology

A Phase II Trial of the Novel Serotonin Type 3 Receptor Antagonist Ramosetron in Japanese Male and Female Patients with Diarrhea-Predominant Irritable Bowel Syndrome

(2008) K. Matsueda et al.   DIGESTION

Afferent hypersensitivity in a mouse model of post-inflammatory gut dysfunction: role of altered serotonin metabolism

(2008) Christopher Keating et al.   JOURNAL OF PHYSIOLOGY-LONDON

A randomized, double-blind, placebo-controlled clinical trial of the effectiveness of the novel serotonin type 3 receptor antagonist ramosetron in both male and female Japanese patients with diarrhea-predominant irritable bowel syndrome

(2008) Kei Matsueda et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY